menu

Quintiles Library

Show Filters
Case Study
When a global pharma company decided to expand co-promotional efforts for a blockbuster brand into new markets, it was seeking rapid market entry. The challenge was clear. In 2005, the pharma company decided to promote a compound internationally, but had a very limited pharmaceutical infrastructure in place across the chosen markets. The decision was to outsource the...
Read more
Case Study
In 2008, Takeda had already developed a European base, with operations in France, Germany, Italy, the UK, Austria and Switzerland. The next stage in their growth strategy for Europe was to move into the Spanish market. The challenge Takeda faced with the launch of its Spanish operations was one of a very tight timeframe — just three months from scratch to launch a...
Read more
Case Study
A woundcare company was having difficulty reaching the UK’s massive number of district nurses — all widespread in geography and without set offices or schedules. Learn what happened when Quintiles fulfilled and managed a collaborative sales promotion, working closely with the company’s sales team.
Read more
Case Study
PharmaMar faced a massive logistical challenge. It needed to quickly mobilize an effective sales force covering a market that spans several different national legislations and more than 20 official languages. Read how, with an established global network uniquely positioned to meet the challenges of the New Health, Quintiles recruited, trained and deployed sales teams in...
Read more
Fact Sheet
 At Quintiles, we offer you a complete solution for your TQT needs including our Phase I, Clinical Pharmacology and ECG Core Labs.
Read more
White Paper
FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy and safety in children. Quintiles’ Dr. Edward Tabor traces the evolving US regulatory guidelines for pediatric studies in an article published in Regulatory Focus, the journal for the Regulatory Affairs Professionals Society. From early regulations allowing...
Explore here
Case Study
With recruitment deadlines down to the wire, Quintiles helped avoid delay of a pediatric nasal influenza vaccine trial by navigating complicated South American regulatory requirements
Read more
Press Release
Research Triangle Park, NC, March 30, 2010 – Quintiles’ Global Central Laboratory in China has won the national “Best Central Lab 2009” award from Shanghai Mental Health Center. “This national award is a wonderful confirmation of all the hard work our Beijing staff have put into developing the right laboratory solutions to deliver clean, reliable and comparable data to...
Read More
Case Study
Pressed to find greater cost efficiencies across the entire development cycle, biopharma companies are outsourcing more clinical trial services. Quintiles provides integrated services with one point of contact and streamlined management.
Read more
Case Study
Through creative strategies and proactive measures, learn how Quintiles achieved both the recruitment targets and database lock eight months early.
Read more
White Paper
Faced with remarkably low approval rates and frequent late phase failures, oncology drug developers need new ways to accelerate and streamline what is often an inefficient, expensive process. One answer is biomarkers, which can confirm a drug’s mechanism of action and help guide patient selection to reduce both risk and cost. In the first of a two-part series, Quintiles...
Explore here
White Paper
An associated Quintiles White Paper discussed the US Food and Drug Administration’s December 2008 Guidance for Industry entitled Diabetes Mellitus — Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes,which made assessment of cardiovascular safety a critical focus during the development of new antidiabetic therapies for Type 2 diabetes...
Explore here
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 17, 2010 – As drug makers around the world continue to navigate the complex and ever-changing landscape referred to as the New Health, many companies are flocking to Asia-Pacific for better access to patients, improved operational efficiencies and increasingly, pharmaceutical innovation. In a new report released today, Ferzaan...
Read More
Press Release
RESEARCH TRIANGLE PARK, N.C., March 15, 2010 – Quintiles today announced that it has successfully relocated its Global Central Laboratory in Japan from Saitama to Tokyo to allow for expansion as Quintiles’ business in Japan and Asia-Pacific continues to grow. The new wholly owned Quintiles facility has expanded testing capabilities with an initial focus on safety testing....
Read More
Press Release
RESEARCH TRIANGLE PARK, NC - March 11, 2010 - Quintiles has expanded its capacity in Africa with the opening of an office in Nairobi, Kenya. A team of locally-based clinical professionals will monitor throughout East Africa, enhancing Quintiles capability to provide clinical research services across the continent. They will complement the work done by Quintiles Ghana...
Read More
White Paper
After the United States issued pediatric drug study requirements, the European Union (EU) passed a regulation that created major changes to clinical studies for pediatric patients. A significant step toward safer dosing for children, the EU guidance opens new questions about pediatric drug development. Quintiles regulatory experts Dr. Raj Kishore and Dr. Edward Tabor...
Explore here
Press Release
RESEARCH TRIANGLE PARK, N.C. – March 8, 2010 – Quintiles today announced the opening of its expanded research facility in London, UK, increasing its Phase I capacity and extending its ability to drive progress in translational medicine. With capacity for 35 patients and healthy volunteers, the extension brings the total number of Phase I beds in London to 105 and globally...
Read More
Media Coverage
Quintiles Asia executives say CROs must evaluate, adjust to new health landscape: An interview with PharmAsia news.
Read more
Case Study
With competing studies and tight timelines challenging recruitment, this cardiology study exceeded its goals by enlisting Quintiles as its new ally
Read more
White Paper
Recent research is producing new treatment approaches for multiple myeloma — giving physicians and patients more options to manage this deadly blood cancer. We heard encouraging news at the 2009 American Society of Hematologists annual meeting. Dr. Harish Dave and Dr. Ben Manderman, respected experts in hematology and oncology, give an overview of the latest studies into...
Explore here